Services / Cancer Care / Research / Clinical Trials /

Clinical Trial

« Back to List

GI 141

Posted by: Fred J. Kudrik, MD, Principal Investigator | Posted Date: November 29, 2010

Status: OPEN - IST
Research Hotline: 803-461-3708

Details: An Open-label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of 5-FU/FA and Oxaliplatin (Modified FOLFOX-6) in Combination With IMC-1121B or IMC-18F1 or Without Investigational Therapy as Second-line Therapy in Patients With Metastatic Colorectal Cancer following Disease Progression on First-line Irinotecan-based Therapy

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share